Brandon Howe
Hospitalist · Baton Rouge, LANPI 1255911723
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 24.5% of the total. Among hospitalist clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$393
- GSK$208
- Merck$141
- Olympus America Inc.$130
- Actelion Pharmaceuticals US, Inc.$126
- Regeneron Healthcare Solutions, Inc.$103
- plus $502 from 13 others
What the payments were for
- Food & beverage$1,58599%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 22 | $393 |
| GSK | 11 | $208 |
| Merck | 7 | $141 |
| Olympus America Inc. | 2 | $130 |
| Actelion Pharmaceuticals US, Inc. | 5 | $126 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
| Boehringer Ingelheim | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $77 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| Insmed, Inc. | 3 | $56 |
| Sanofi | 3 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $29 |
| Inogen, Inc. | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
$1,602 in reported general payments places this provider in the 90th percentile of 301 hospitalist providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,592 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $9,072 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $890 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $408 |
| Atorvastatin Calcium | 33 | $358 |
| Gabapentin | 15 | $218 |
| Pantoprazole Sodium | 19 | $197 |
| Escitalopram Oxalate | 15 | $194 |
| Losartan Potassium | 15 | $122 |
| Tramadol Hcl | 11 | $114 |
| Metformin Hcl | 11 | $39 |
| Prednisone | 12 | $27 |
| Furosemide | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $208 | $9,07212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 301 hospitalist providers in Louisiana.
Other hospitalist in Baton Rouge
- David MickeyBaton Rouge$6K
- Haroon MujahidBaton Rouge$4K
- Robert CauseyBaton Rouge$2K
- Brandi FontenotBaton Rouge$2K
- Brian GouriBaton Rouge$2K
- Melanie McKnightBaton Rouge$2K
- Kevin DeanBaton Rouge$2K
- Amy GiarrussoBaton Rouge$2K
- Joe Marie DizonBaton Rouge$2K
- Daniel RobbinsBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.